Maryam Esfahani

1.1k total citations · 1 hit paper
48 papers, 900 citations indexed

About

Maryam Esfahani is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Maryam Esfahani has authored 48 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Organic Chemistry and 9 papers in Molecular Biology. Recurrent topics in Maryam Esfahani's work include Metal complexes synthesis and properties (11 papers), Synthesis and biological activity (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Maryam Esfahani is often cited by papers focused on Metal complexes synthesis and properties (11 papers), Synthesis and biological activity (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Maryam Esfahani collaborates with scholars based in Iran, United States and Canada. Maryam Esfahani's co-authors include Mahdi Behzad, Casey Marjerrison, John E. Greedan, Sahar Zinatloo‐Ajabshir, Mohammad Taghi Goodarzi, Kaveh Alavi, Fereshteh Mehri, Ahmad Movahedian, Alireza Abbasi and Mojtaba Panjehpour and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Maryam Esfahani

44 papers receiving 883 citations

Hit Papers

Enhanced electrochemical hydrogen storage performance of ... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryam Esfahani Iran 16 150 147 139 112 75 48 900
Yunfang Liu China 25 80 0.5× 85 0.6× 251 1.8× 361 3.2× 46 0.6× 116 1.6k
Lingyan Zhang China 22 96 0.6× 77 0.5× 283 2.0× 123 1.1× 147 2.0× 132 1.6k
Xingxing Zhang China 16 41 0.3× 154 1.0× 250 1.8× 65 0.6× 79 1.1× 65 1.3k
Shengxian Li China 25 74 0.5× 96 0.7× 469 3.4× 109 1.0× 132 1.8× 95 1.9k
Lingyi Wang Taiwan 22 58 0.4× 92 0.6× 291 2.1× 87 0.8× 123 1.6× 69 1.6k
Weihong Liu China 20 130 0.9× 183 1.2× 474 3.4× 70 0.6× 55 0.7× 86 1.4k
Zongjian Liu China 22 73 0.5× 101 0.7× 500 3.6× 84 0.8× 203 2.7× 47 2.0k
Yuying Feng China 22 75 0.5× 50 0.3× 255 1.8× 448 4.0× 69 0.9× 55 1.2k

Countries citing papers authored by Maryam Esfahani

Since Specialization
Citations

This map shows the geographic impact of Maryam Esfahani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Esfahani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Esfahani more than expected).

Fields of papers citing papers by Maryam Esfahani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Esfahani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Esfahani. The network helps show where Maryam Esfahani may publish in the future.

Co-authorship network of co-authors of Maryam Esfahani

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Esfahani. A scholar is included among the top collaborators of Maryam Esfahani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Esfahani. Maryam Esfahani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Esfahani, Maryam & Fereshteh Mehri. (2024). Homeostatic changes of trace elements in diazinon toxicity in rat model: The beneficial role of resveratrol. Toxicology Reports. 13. 101719–101719. 1 indexed citations
3.
Esfahani, Maryam, et al.. (2023). Cardioembolic stroke, the most common subtype of stroke in COVID 19: A single center experience from Isfahan, Iran. Journal of Research in Medical Sciences. 28(1). 10–10. 2 indexed citations
5.
Esfahani, Maryam, et al.. (2023). The Effects of Resveratrol on Silica-Induced Lung Oxidative Stress and Inflammation in Rat. Safety and Health at Work. 14(1). 118–123. 9 indexed citations
6.
Esfahani, Maryam, et al.. (2023). Protective effect of flaxseed oil the on diazinon-induced hepatotoxicity in male rats. Proceedings of the Indian National Science Academy. 89(3). 655–663. 4 indexed citations
8.
Moghadam, Mahboube Eslami, et al.. (2023). New platinum (II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer. JBIC Journal of Biological Inorganic Chemistry. 28(5). 519–529. 17 indexed citations
9.
Mehri, Fereshteh, Akram Ranjbar, Naghmeh Shirafkan, Sara Soleimani Asl, & Maryam Esfahani. (2022). The protective effect of resveratrol on diazinon‐induced oxidative stress and glucose hemostasis disorder in rats' liver. Journal of Biochemical and Molecular Toxicology. 36(7). e23063–e23063. 14 indexed citations
10.
11.
Esfahani, Maryam, Casey Marjerrison, John E. Greedan, & Mahdi Behzad. (2021). Catalytic performance of a wide range of rare-earth titanate pyrochlore (RE2Ti2O7, RE = Sm, Gd, Dy, and Yb) microstructures in the epoxidation of cyclooctene: An electro-structural investigation. Materials Today Communications. 29. 102888–102888. 4 indexed citations
12.
Esfahani, Maryam, et al.. (2021). Synthesis, crystal structure and battery-like studies on a new acylpyrazolone-based mixed-ligand Cu(II) complex. Research on Chemical Intermediates. 48(2). 575–591. 3 indexed citations
13.
Mehri, Fereshteh, Maryam Esfahani, Ali Heshmati, Ensiyeh Jenabi, & Salman Khazaei. (2020). The prevalence of ochratoxin A in dried grapes and grape-derived products: a systematic review and meta-analysis. Toxin Reviews. 41(1). 347–356. 20 indexed citations
14.
Mehri, Fereshteh, Mohammad Taghi Goodarzi, & Maryam Esfahani. (2020). The Possible Protective Effect of Resveratrol on DiazinonInduced Oxidative Stress and Hepatic Injury. SHILAP Revista de lepidopterología. 8(1). 44–48. 3 indexed citations
15.
Esfahani, Maryam, et al.. (2017). The Role of Adipokines in the Pathophysiology of Cardiovascular Diseases. Razi Journal of Medical Sciences. 24(157). 51–73. 2 indexed citations
16.
Esfahani, Maryam, et al.. (2015). Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy. Expert Opinion on Biological Therapy. 15(12). 1739–1755. 19 indexed citations
17.
Tavilani, Heidar, Amir Fattahi, Maryam Esfahani, et al.. (2014). Genotype and phenotype frequencies of paraoxonase 1 in fertile and infertile men. Systems Biology in Reproductive Medicine. 60(6). 361–366. 14 indexed citations
18.
Tavilani, Heidar & Maryam Esfahani. (2012). Gene polymorphism and hypertension. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Bigler, Robert D., et al.. (1990). Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.. Proceedings of the National Academy of Sciences. 87(13). 4981–4985. 25 indexed citations
20.
Bigler, Robert D., et al.. (1989). Effect of low-density lipoprotein on the expression of high affinity Fcγ receptors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1011(2-3). 102–109. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026